Alpha2 adrenergic agonists for attention deficit hyperactivity disorder (ADHD)

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

In people of all ages, to assess the efficacy and safety of alpha2 agonists, alone or as an adjunct therapy, in treating core symptoms of ADHD or hyperkinetic disorder, associated comorbid symptoms and side effects.